The novel role of C-reactive protein in cardiovascular disease: Risk marker or pathogen
about
Hypolipidemic and antihypertensive drugs for prevention of cardiovascular complications in patients with rheumatoid arthritisSaliva as a diagnostic tool for oral and systemic diseasesImpact of Obstructive Sleep Apnea Syndrome on Endothelial Function, Arterial Stiffening, and Serum Inflammatory Markers: An Updated Meta-analysis and Metaregression of 18 Studies.C-reactive protein: the underlying cause of microvascular dysfunction in rheumatoid arthritis.A Smartphone-Based Colorimetric Reader for Human C-Reactive Protein Immunoassay.Relationship between high-sensitivity C-reactive protein serum levels and the severity of coronary artery stenosis in patients with coronary artery disease.Sent to destroy: the ubiquitin proteasome system regulates cell signaling and protein quality control in cardiovascular development and disease.Inflammation-induced atherosclerosis as a target for prevention of cardiovascular diseases from early lifeExamination of the effect of the annealing cation on higher order structures containing guanine or isoguanine repeatsEndothelial function in individuals with coronary artery disease with and without type 2 diabetes mellitus.The effect of Helicobacter pylori eradication on macrophage migration inhibitory factor, C-reactive protein and fetuin-a levels.Evaluation of Toll-Like receptor 2 and 4 RNA expression and the cytokine profile in postmenopausal women with metabolic syndrome.Validation of a commercially available automated canine-specific immunoturbidimetric method for measuring canine C-reactive proteinAtherosclerosis in type 2 diabetes: a role for fibrate therapy?Body mass and white matter integrity: the influence of vascular and inflammatory markers.Declines in inflammation predict greater white matter microstructure in older adults.Integrative computational and experimental approaches to establish a post-myocardial infarction knowledge map.Helicobacter pylori gastritis, a presequeale to coronary plaque.Improved blood biomarkers but no cognitive effects from 16 weeks of multivitamin supplementation in healthy older adults.Associations between transition-specific stress experience, nocturnal decline in ambulatory blood pressure, and C-reactive protein levels among transgender men.Effect of exercise training modality on C-reactive protein in type 2 diabetesC-reactive protein in vulnerable coronary plaques.Exploring metabolic dysfunction in chronic kidney disease.Inflammation and exercise (INFLAME): study rationale, design, and methods.Early detection and management of the high-risk patient with elevated blood pressure.Clinical implications of C-reactive protein as a predictor of vascular risk.Risk assessment in the patient with established peripheral arterial disease.Considering the inclusion of metabolic and cardiovascular markers in the Panel Study of Income Dynamics.Biomarkers of inflammation and thrombosis as predictors of near-term mortality in patients with peripheral arterial disease: a cohort study.Role of IGF-1 in glucose regulation and cardiovascular disease.Aldosterone Receptor Antagonism Reduces Urinary C-Reactive Protein Excretion in Angiotensin II-Infused, Hypertensive Rats.White blood cell count predicts all-cause mortality in patients with suspected peripheral arterial diseaseInhibiting C-reactive protein for the treatment of cardiovascular disease: promising evidence from rodent models.Resistance training, visceral obesity and inflammatory response: a review of the evidence.Perspectives on the value of biomarkers in acute cardiac care and implications for strategic managementPredicting therapeutic response in patients with heart failure: the story of C-reactive protein.Association of cardiorespiratory fitness and adiposity with inflammatory biomarkers in young adults.Association study of CRP gene and ischemic stroke in a Chinese Han population.C-Reactive Protein Gene Contributes to the Genetic Susceptibility of Hemorrhagic Stroke in Men: a Case-Control Study in Chinese Han Population.Effects of the vasodilating beta-blocker nebivolol on smoking-induced endothelial dysfunction in young healthy volunteers.
P2860
Q24242787-2D749D79-6B88-4AF2-BC9E-09CD80206FE2Q26764819-218043AC-1B91-41BF-9BE2-670855868576Q30488543-4198A345-FBD9-44DE-9DF2-DD55C1B8CA83Q33375902-86280CED-E64A-43AD-8EA0-71CA91F3012AQ33453332-7544C19D-9D2E-4FAA-8CFF-D61AD4C8572BQ33596943-97C84187-6CD8-410E-A1FA-82977F359CF7Q33679929-F47CD983-DE75-4667-9067-9CEAC0C5E826Q33735189-899B1BCE-D647-41C8-90C4-38B5DDFA9E78Q33924776-CF8ED955-D769-4A65-93EC-4CA04115DB10Q33936833-2B8508DC-E0A6-478E-86C5-DFD90B437C2BQ34102994-66BA6E6A-EFCB-44AD-BE55-E6D3265449BCQ34361828-B9076482-64F9-4810-8FEB-59CDA2BA5D09Q34639718-B55A036F-6FFD-4D5E-8351-6AAD22D02AB4Q34730108-B389824D-743E-4A7E-8C3A-B66CC308B867Q35023378-DE4E8F5D-708F-47A5-BB2F-E4B7C98BA45DQ35116903-6300B8D9-3EB0-491C-8CA6-E939F2509F3FQ35126269-552788D0-2E79-4B91-9E91-7FFA37D4A9B5Q35289835-6407F892-7897-44F9-B17C-88F304400826Q35658222-849FE1E3-37F8-4009-95E7-5F7AEAE6D816Q35668383-B74CBCBF-3C14-4BE4-8635-FD8EA0916F36Q35937016-51B32B72-E7F9-466D-A0DF-96657A8C9268Q36014383-F5BDFEC5-A087-4FAB-B24C-A77F86587EB5Q36123347-264A5606-6F14-4C46-ABDA-EE1332A3E60EQ36732620-A82C28A4-A2D7-4EA7-8600-B75BB1B97317Q36812763-EEDD24B1-0E1A-4753-812C-F80812B8CAEAQ36903050-DFF228A4-BB12-41A7-983B-2CA02E9C12E9Q37019601-123E2525-649A-4FDE-BA1E-DD1FDD5D7016Q37056497-D6F60E74-979A-4FFC-8684-C83B1673DD5DQ37122026-28FDD58E-0028-4120-BF8D-C2DF91594D02Q37269401-F1E3B118-2A3B-4F86-B56C-CA0C1D973746Q37340088-59342891-F62B-44E5-A8F1-78F5B1D144D5Q37445745-928B0EFF-90A7-46C5-A6C9-ADBD484DA616Q37717823-6C964771-F170-40E2-98C7-A1BD9D98E4D7Q37990074-BA682D35-09B8-4AB9-8DE6-5248465AD506Q38138969-0638A060-9954-4C81-9B4D-DAAD1CEE2104Q38314153-A39B99C4-6BF7-4869-880E-5A14149D52EAQ39017029-BA2902EC-49EB-4180-A2C0-FAA49AEB53FDQ39572316-7B0F6603-C6F9-404F-A7B9-062DFE7900D1Q40117457-74E963DC-D89E-4159-A34C-B13EAFF4BA15Q41117670-EBB73C76-F98F-446B-9918-2BD1D4E91424
P2860
The novel role of C-reactive protein in cardiovascular disease: Risk marker or pathogen
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
The novel role of C-reactive protein in cardiovascular disease: Risk marker or pathogen
@ast
The novel role of C-reactive protein in cardiovascular disease: Risk marker or pathogen
@en
The novel role of C-reactive protein in cardiovascular disease: Risk marker or pathogen
@en-gb
The novel role of C-reactive protein in cardiovascular disease: Risk marker or pathogen
@nl
type
label
The novel role of C-reactive protein in cardiovascular disease: Risk marker or pathogen
@ast
The novel role of C-reactive protein in cardiovascular disease: Risk marker or pathogen
@en
The novel role of C-reactive protein in cardiovascular disease: Risk marker or pathogen
@en-gb
The novel role of C-reactive protein in cardiovascular disease: Risk marker or pathogen
@nl
altLabel
The novel role of C-reactive protein in cardiovascular disease: risk marker or pathogen
@en
prefLabel
The novel role of C-reactive protein in cardiovascular disease: Risk marker or pathogen
@ast
The novel role of C-reactive protein in cardiovascular disease: Risk marker or pathogen
@en
The novel role of C-reactive protein in cardiovascular disease: Risk marker or pathogen
@en-gb
The novel role of C-reactive protein in cardiovascular disease: Risk marker or pathogen
@nl
P2093
P1476
The novel role of C-reactive protein in cardiovascular disease: Risk marker or pathogen
@en
P2093
Andrew J. Boyle
Andrew M. Wilson
Marno C. Ryan
P304
P356
10.1016/J.IJCARD.2005.01.068
P407
P577
2006-01-01T00:00:00Z